Alcohol: Thiamine and or Magnesium 1

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

December 16, 2016

Primary Completion Date

April 2, 2018

Study Completion Date

June 19, 2018

Conditions

Alcohol WithdrawalLactic AcidosisVitamin B1 DeficiencyMagnesium DeficiencyWernicke Encephalopathy

Interventions

DRUG

Magnesium Sulfate

Intravenous (Magnesium Sulphate) MgSO4 2 grams IV over 20 minutes

DRUG

Pabrinex

standard treatment

Trial Locations (1)

Glasgow Royal Infirmary, Glasgow

All Listed Sponsors

lead

Glasgow Royal Infirmary

OTHER

NCT03466528 - Alcohol: Thiamine and or Magnesium 1 | Biotech Hunter | Biotech Hunter